Radioembolization gains continuous traction as a primarily palliative radiation treatment for
hepatic tumours. A form of nuclear medicine therapy, Yttrium-90 containing microspheres …

Inert microspheres, labeled with several radionuclides, have been developed during the last
two decades for the intra-arterial treatment of liver tumors, generally called Selective …

The International Commission on Radiation Units and Measurements (ICRU), since its
inception in 1925, has had as its principal objective the development of internationally …

The aim of this standard operational procedure is to standardize the methodology employed
for the evaluation of pre-and post-treatment absorbed dose calculations in 90 Y microsphere …

Purpose The aim of this study was to optimize the dosimetric approach and to review the
absorbed doses delivered, taking into account radiobiology, in order to identify the optimal …

With an increasing variety of radiopharmaceuticals for diagnostic or therapeutic nuclear
medicine as valuable diagnostic or treatment option, radiobiology plays an important role in …

Radioembolization (RE) is a relatively novel treatment modality for primary and secondary
hepatic malignancies. Microspheres embedded with a β-emitting radioisotope are injected …

Purpose In Y90 radioembolization, the number of microspheres infused varies by more than
a factor of 20 over the shelf-life of the glass radioembolization device. We investigated the …

Background The aim of this study was to investigate the relationship between absorbed
dose and response of colorectal cancer liver metastases treated with [90 Y]-resin …

Transarterial radioembolization (TARE) with beta particle emitting microspheres via Yttrium-
90 decay has become a fundamental component of the contemporary Interventional …